These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 86792)

  • 1. Monkey scoliosis.
    Taffs LF; Magrath DI; Lytton NA
    Lancet; 1979 May; 1(8125):1078-9. PubMed ID: 86792
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental scoliosis in primates: a neurological cause.
    Pincott JR; Taffs LF
    J Bone Joint Surg Br; 1982; 64(4):503-7. PubMed ID: 6284765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The behaviour of Sabin attenuated poliovirus strains in the central nervous system of rhesus monkeys.
    Arya SC
    J Biol Stand; 1977; 5(4):275-81. PubMed ID: 200628
    [No Abstract]   [Full Text] [Related]  

  • 4. Monkey neurovirulence of live, attenuated (Sabin) type I and type II poliovirus vaccines.
    Marsden SA; Boulger LR; Magrath DI; Reeve P; Schild GC; Taffs LF
    J Biol Stand; 1980; 8(4):303-9. PubMed ID: 7009616
    [No Abstract]   [Full Text] [Related]  

  • 5. Substantia nigra lesions in rhesus monkeys injected with attenuated polioviruses.
    Arya SC
    J Biol Stand; 1976; 4(4):337-9. PubMed ID: 825516
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of a mathematical model for neurovirulence assay of attenuated poliovirus.
    Arya SC
    J Biol Stand; 1977; 5(4):283-7. PubMed ID: 200629
    [No Abstract]   [Full Text] [Related]  

  • 7. Live attenuated oral poliovirus vaccine: problem areas in production.
    Beale AJ
    Rev Infect Dis; 1984; 6 Suppl 2():S334. PubMed ID: 6429813
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the neurovirulence test of poliomyelitis-live vaccine. V. A statistical method for the evaluation of the experiment for the comparison of neurovirulence in the monkey].
    Seinsche D; Bonin O; Unterharnscheidt F; Schmidt K; Schmidt I
    Arch Psychiatr Nervenkr (1970); 1966; 208(5):433-46. PubMed ID: 4291332
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the neurovirulence test of poliomyelitis-live vaccine. V. A statistical method for the evaluation of the experiment for the comparison of neurovirulence in the monkey].
    Seinsche D; Bonin O; Unterharnscheidt F; Schmidt K; Schmidt I
    Arch Psychiatr Nervenkr (1970); 1966; 208(5):433-46. PubMed ID: 4291066
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neurovirulence of a new attenuated poliovirus type 3 (USOL-D) in a monkey experiment].
    Unterharnscheidt F; Simon J
    Naturwissenschaften; 1965 Sep; 52(17):502. PubMed ID: 4956397
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of candidates for new type 2 and type 3 oral poliovirus vaccines.
    Kohara M; Abe S; Yoshioka I; Nomoto A
    Dev Biol Stand; 1993; 78():141-8. PubMed ID: 8388824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
    Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polio eradication, cessation of vaccination and re-emergence of disease.
    Minor PD
    Nat Rev Microbiol; 2004 Jun; 2(6):473-82. PubMed ID: 15152203
    [No Abstract]   [Full Text] [Related]  

  • 14. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.
    Furesz J; Contreras G
    Dev Biol Stand; 1993; 78():61-70. PubMed ID: 8388832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the viral RNA sequence heterogeneity for control of OPV neurovirulence.
    Chumakov K; Norwood L; Parker M; Dragunsky E; Taffs R; Ran Y; Ridge J; Levenbook I
    Dev Biol Stand; 1993; 78():79-89; discussion 88-9. PubMed ID: 8388834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of two schedules for administering trivalent oral poliovaccine].
    Hu XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 1985 Sep; 19(5):275-7. PubMed ID: 3004841
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurovirulence testing of oral poliovaccine in the rhesus monkey.
    Arya SC
    Indian J Pathol Microbiol; 1976 Jul; 19(3):185-94. PubMed ID: 186408
    [No Abstract]   [Full Text] [Related]  

  • 18. International comparison of species of monkey used for the neurovirulence test for oral poliomyelitis vaccine.
    Boulger LR; Arya SC; Ahourai P; Marsden SA
    J Biol Stand; 1978 Jul; 6(3):233-42. PubMed ID: 102647
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential use of new poliomyelitis vaccines: memorandum from a WHO meeting.
    Bull World Health Organ; 1990; 68(5):545-8. PubMed ID: 1963117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.
    Levenbook I; Nomura T
    Lab Anim Sci; 1997 Apr; 47(2):118-20. PubMed ID: 9150487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.